))
Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.
Manage episode 497309753 series 3677839
Content provided by Tyler Menichiello. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Tyler Menichiello or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode of Better Biopharma, Abalone Bio's CEO and co-founder, Richard Yu, Ph.D., explains how the company's functional antibody selection technology (FAST) platform differs from traditional affinity screening.
Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/
Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/
Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions
5 episodes
Share
